ClinicalTrials.gg
Status unknownNCT02345759KetoPsyUpdated Aug 7, 2018

Psychological Aspects and Patients Compliance to Restricted-protein Regimens in Chronic Kidney Disease

An observational study in Psychological Characteristics Involved in Dietary Compliance, sponsored by Anemia Working Group Romania. Status unknown at 1 site in Romania. Open to participants aged 18 Years to 85 Years. Per ClinicalTrials.gov, last updated 2018-08-07.

Sponsored by Anemia Working Group Romania · Observational

How we know

The sponsor has not verified this record recently (last verified Aug 2018), so the status shown — last known as Recruiting — may be out of date.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Case-control
Time perspective
Prospective
Enrollment
120
Ages
18 Years to 85 Years
Sex
All
01

Study summary

Dietary management of CKD patients proved important to postpone dialysis. Long-term compliance to protein-restricted diets was discussed. Psychological aspects involved in certain dietary behaviour have never been studied.

Read the detailed description

The interest in dietary management resurged, since the high prevalence of revealed a major impact not only on morbidity, mortality, social activities and patients' quality of life, but also on health budget.

Although protein-restricted diets are used for more than a century in patients with advanced Chronic Kidney Disease (CKD), their efficacy and safety is still debatable. Enough evidence has being accumulated on their role in postponing dialysis initiation in compliant patients. Consequently, the long-term compliance to the diet is discussed. Psychological aspects of compliant patients are certainly involved. Identification of certain psychological predictors of dietary compliance could help to select the patients who are more likely to be compliant and therefore to benefit from such an intervention. Moreover, short-term or long-term psychological intervention addressing these factors could increase patient long-term compliance.

Accordingly, we are aiming to evaluate psychological characteristics of Chronic Kidney Disease patients in relation with their compliance to protein-restricted regimens.

02

Conditions studied

  • Psychological Characteristics Involved in Dietary Compliance

Browse trials for

Keywords

  • CKD patients
  • protein-restricted diets
  • compliance
  • psychological aspects
03

In context

Patient Compliance

752 studies on the registry are indexed under Patient Compliance; 72 are open to participants now.

This study's planned enrollment of 120 is below the median of 184 across 208 observational studies indexed under Patient Compliance.

Browse Patient Compliance studies →

Lead sponsor

Anemia Working Group Romania is the lead sponsor of 9 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 85 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Probability sample

Study population

All consecutive adult patients, with stage 4-5ND CKD (estimated glomerular filtration by MDRD formula of less than 30 mL/min per year) included in the dietary intervention program of "Dr Carol Davila" Teaching Hospital of Nephrology coming for the scheduled visits between January the 1st and June the 30th, 2014 will be considered eligible.

Those who will sign the informed consent will be included in the study; the specially-designed questionnaire will be administered. Simultaneously, their routine assesment, including the dietary compliance, manifestations of CKD and the nutritional status will be performed, as recommended by the Romanian Best Practice Guidelines for CKD [28].

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • adult patients
  • stage 4+ CKD
  • good nutritional status (Subjective Global Assessment score A/B and serum albumin ≥3.5 g/dL)
  • declared potentially good compliance with a low protein diet and agreed to follow the monitoring schedule are considered for the program

Exclusion criteria

Exclusion Criteria:

  • poorly controlled arterial blood pressure (≥145/85 mm Hg)
  • uncontrolled diabetes mellitus
  • other relevant comorbidities (heart failure, active hepatic disease, digestive diseases with malabsorption, inflammation/anti-inflammatory therapy)
  • uremic complications (pericarditis, polyneuropathy)
  • feeding inability (anorexia, nausea)
05

Study design

Observational model
Case-control
Time perspective
Prospective
Enrollment
120 participants (estimated)
Patient registry
No

Groups and cohorts

  • Keto-diet group

    Vegetarian very low protein regimen (0.3 g proteins/kg ideal body weight per day) supplemented with ketoanalogues of essential amino acids (Ketosteril®, Fresenius Kabi, Bad Homburg, Germany), 1 capsule for every 5 kg of ideal dry body weight per day.

  • Conventional LPD group

    0.6 g/kg per day, including high biological value proteins

06

What researchers measure

Primary outcomes

  1. Compliance to the protein-restricted diet

    The compliance to the diet is appreciated to be good if both the achieved protein intake and the achieved energy is in the range of ±10% of the recommended values.

    Time frame: 12 months

Secondary outcomes

  1. Parameters related to renal function (The decline in glomerular filtration rate (GFR) GFR decline

    The decline in glomerular filtration rate (GFR)

    Time frame: 12 months

  2. Psychological parameter - self-efficacy score

    Self-efficacy score derives from the self-efficacy scale.

    Time frame: 12 months

  3. Nitrogen balance (Serum urea level)

    Serum urea level

    Time frame: 12 months

  4. Metabolic acidosis (Serum bicarbonate level)

    Serum bicarbonate level

    Time frame: 12 months

  5. Calcium-phosphorus metabolism abnormalities (Serum calcium)

    Serum calcium

    Time frame: 12 months

  6. Calcium-phosphorus metabolism abnormalities (Serum phosphates level)

    Serum phosphates level

    Time frame: 12 months

  7. Psychological parameter - illness perception (Sub-scores derived from illness perception questionnaire)

    Sub-scores derived from illness perception questionnaire: the higher this score, the worse is patient's perception on the disease.

    Time frame: 12 months

  8. Mental status - vitality index

    Vitality score derived from mental component of SF-36

    Time frame: 12 months

  9. Psychological parameter -mental score

    The mental score looks at depression. Psychological difficulties interfere with the initiation of compliance behaviours.

    Time frame: 12 months

Other outcomes

  1. Safety parameters (Subjective Global Assessment, anthropometric markers, biochemical parameters, and serum total cholesterol)

    Parameters of nutritional status are predefined as safety parameters. Subjective Global Assessment anthropometric markers, and biochemical parameters

    Time frame: 12 months

07

Study locations

1 of 1 sites recruiting
  • Spitalul Clinic de Nefrologie "Dr Carol Davila"
    Bucuresti, 010731, Romania
    Recruiting
    • Liliana Garneata, MD, PhD · Contactlilianagarna@yahoo.com · 0722619358
    • Cristina Drugau, MD · Contactcristina.drugau@yahoo.com
    • Cristina Drugau, MD · Sub investigator
    • Gabriel Stefan, MD · Sub investigator
    • Paula Larisa Luca, MD · Sub investigator
    • Alexandra Stancu, MD · Sub investigator
08

Timeline

Tracking since Sep 25, 2026
Not marked actual or estimatedDates not marked actual or estimated

The record gives a start of Jan 2013, a primary completion of Sep 2020 and a completion of Dec 2020. It does not say whether these dates are actual or estimated.

How these figures are worked out, and which studies are left out of them.

Registered
Aug 23, 2014
First posted
Jan 26, 2015
Start
Jan 2013
Primary completionEst.
Sep 2020
CompletionEst.
Dec 2020
Last update
Aug 7, 2018
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Aug 7, 2018, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT02345759
Lead sponsor
Anemia Working Group Romania
Responsible party
Sponsor
First posted
Jan 26, 2015
Start date
Jan 2013
Primary completion
Sep 2020 (estimated)
Completion
Dec 2020 (estimated)
Last update
Aug 7, 2018

Study contacts

Liliana Garneata, MD, PhD
Contact
lilianagarna@yahoo.com
+40722619358
Cristina Drugau
Contact
cristina.drugau@yahoo.com
Gabriel Mircescu, Professor of Nephrology
study chair · Spitalul Clinic de Nefrologie "Dr Carol Davila"
Liliana Garneata, MD, PhD
study director · Spitalul Clinic de Nefrologie "Dr Carol Davila"
Cristina Drugau, MD
principal investigator · Spitalul Clinic de Nefrologie "Dr Carol Davila"
Evy Dehelean, Psychologist
principal investigator · International Health Care Systems Romania

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2018. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion